GrayBio is a biotechnology company pioneering a new wave of precision radiotherapeutics—an innovative approach to cancer treatment that targets and destroys cancer cells wherever they are, while sparing healthy tissue.
Built on a proprietary, modular platform invented at Duke University, GrayBio is developing a broad pipeline of safer, more effective therapies for patients with limited treatment options.
Follow us to see how we're reshaping the future of cancer care and improving patients' lives.
Company Details
Graybio Questions
Graybio's LinkedIn profile is https://www.linkedin.com/company/graybio
Graybio has
1 employees.
View email and phone details for 1
employees at Graybio.
Graybio's industry is
Biotechnology Research
Graybio's categories are Biotechnology Research
Graybio's founding year is 2025
